PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Blue Shield of CaliforniaAll Plans · Coverage · Medical Policy · CA · Cardiology, NeurologyHigh impact

Ambulatory Event Monitors and Mobile Cardiac Outpatient Telemetry (2.02.08)

Effective date
Aug 1, 2026
Identified
Jul 31, 2026

Summary

Blue Shield of California medical policy 2.02.08, Ambulatory Event Monitors and Mobile Cardiac Outpatient Telemetry, has an effective date of August 1, 2026. Outpatient cardiac telemetry (mobile cardiac outpatient telemetry, MCOT) may be considered medically necessary as a diagnostic alternative to ambulatory event monitors for infrequent symptoms (less frequently than every 48 hours) suggestive of cardiac arrhythmias, such as severe palpitations, dizziness, or clinically significant presyncope or syncope, when the criteria below are met. Under the prior policy statement this use was considered investigational. Outpatient cardiac telemetry for any other condition, disease or symptoms, and ambulatory event monitors for asymptomatic individuals with risk factors for arrhythmia, are considered investigational.

Get alerts when payers change rules like this one

We check Blue Shield of California and other payers every day and email you when a change matches your specialty and state.

Get Blue Shield of California alertsPolicy Monitoring is free. No card required.

What to do

Action · 6 steps
01Already effective August 1, 2026: For mobile cardiac outpatient telemetry (codes 93228 and 93229), confirm that one of the policy criteria is met before billing.
02Criterion 1: recurrent unexplained clinically significant presyncope, syncope, severe palpitations or dizziness, when symptoms are thought to be due to a cardiac arrhythmia as the most likely diagnosis, a Holter monitor and/or external AEM has been nondiagnostic or contraindicated, and the record documents that real-time monitoring is essential for patient safety and will lead to immediate clinical changes such as medication or other emergent procedures.
03Criterion 2: evaluation of cryptogenic stroke thought to be caused by atrial fibrillation, with a non-diagnostic 24- to 48-hour Holter monitor or 48-hour telemetry.
04Documentation for clinical review should include a history and physical and/or cardiology consultation report with the clinical justification for the device, a description and frequency of symptoms, the device name and type including vendor name, documentation of a prior Holter or external ambulatory event monitor trial when applicable, and, when atrial fibrillation applies, past catheter ablation history and anticoagulation status with any plan for discontinuation.
05After service, provide the ambulatory monitor report.
06Questions about applicability go to the Prior Authorization Department at (800) 541-6652.

Codes mentioned

9322893229R00.2R42R55I63.9

Original notice

Ambulatory Event Monitors and Mobile Cardiac Outpatient Telemetry (2.02.08)
blueshieldca.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account